Navigation Links
LSUHSC awarded $4 million to understand effect of THC on HIV
Date:7/7/2010

New Orleans, LA Patricia Molina, MD, PhD, Professor and Head of Physiology at LSU Health Sciences Center New Orleans, has been awarded a $4 million grant over five years by the National Institute on Drug Abuse of the National Institutes of Health to study how cannabinoids, the principal psychoactive component of marijuana, produce subtle changes in gene activity that affect how a person responds to HIV infection.

As the grant's principal investigator, Dr. Molina will lead a team of geneticists, microbiologists, pharmacologists, and physiologists to explore the mechanisms involved in the anti-inflammatory effects and suppression of viral replication associated with prolonged survival in a model of HIV. The hypothesis will be tested with the following specific aims:

  • Demonstrate that chronic cannabinoid treatment decreases tissue inflammation
  • Identify the mechanisms of cannabinoid-induced suppression of inflammation
  • Examine the direct and indirect mechanisms by which cannabinoids decrease viral replication

While the ability of cannabinoids to suppress inflammation and viral replication has been reported by others and confirmed by ongoing studies in Dr. Molina's lab, the mechanisms involved are not known.

"The expected results will have a profound impact on the potential development of targeted therapeutic interventions to ameliorate HIV disease progression," notes Dr. Molina.


'/>"/>

Contact: Leslie Capo
lcapo@lsuhsc.edu
504-568-4806
Louisiana State University Health Sciences Center
Source:Eurekalert

Page: 1

Related biology news :

1. LSUHSC researcher finds surprising link between sugar in drinks and blood pressure
2. LSUHSC research increases understanding of drug metabolism
3. LSUHSC researcher finds first inherited prostate cancer genetic mutation in African-American men
4. LSUHSC awarded multi-million dollar grant to reduce pneumonia
5. LSUHSCs England plays key role in developing new ALS treatment guidelines
6. LSUHSC researchers working to prevent diabetic neuropathy
7. Grant supports LSUHSC research on how like cell receptor systems determine very different functions
8. LSUHSC shows for first time infant inhalation of ultrafine air pollution linked to adult lung disease
9. LSUHSCs Bazan awarded ARRA grant to preserve vision
10. LSUHSC research helps link schizophrenia to specific DNA region
11. LSUHSCs Kolls awarded $1.8 million to improve vaccine strategies for P. carinii pneumonia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/5/2017)... YORK , April 5, 2017 Today ... is announcing that the server component of the HYPR ... known for providing the end-to-end security architecture that empowers ... HYPR has already secured over 15 million ... makers including manufacturers of connected home product suites and ...
(Date:4/3/2017)... WASHINGTON , April 3, 2017 /PRNewswire-USNewswire/ ... single-cell precision engineering platform, detected a statistically ... cell product prior to treatment and objective ... highlight the potential to predict whether cancer ... prior to treatment, as well as to ...
(Date:3/30/2017)... , March 30, 2017 Trends, opportunities and ... and behavioral), by technology (fingerprint, AFIS, iris recognition, facial ... and others), by end use industry (government and law ... financial and banking, and others), and by region ( ... , Asia Pacific , and the ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... ... October 11, 2017 , ... Personal eye wash is a basic first aid supply for ... time. So which eye do you rinse first if a dangerous substance enters both eyes? ... Eye Wash with its unique dual eye piece. , “Whether its dirt and debris, ...
(Date:10/11/2017)... a leading provider of patient support solutions, has announced the ... which will launch this week. The VMS CNEs will address ... enhance the patient care experience by delivering peer-to-peer education programs ... to help women who have been diagnosed and are being ... ...
(Date:10/11/2017)... ... October 11, 2017 , ... A new study ... in frozen and fresh in vitro fertilization (IVF) transfer cycles. The ... IVF success. , After comparing the results from the fresh and frozen transfer ...
(Date:10/10/2017)... Angeles, CA (PRWEB) , ... ... ... Inc., a development-stage cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, ... uses of targeted HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in ...
Breaking Biology Technology: